U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C13H11N3.H2O4S
Molecular Weight 516.572
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROFLAVINE HEMISULFATE

SMILES

OS(O)(=O)=O.NC1=CC2=NC3=CC(N)=CC=C3C=C2C=C1.NC4=CC5=NC6=CC(N)=CC=C6C=C5C=C4

InChI

InChIKey=YADYXCVYLIKQJX-UHFFFAOYSA-N
InChI=1S/2C13H11N3.H2O4S/c2*14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10;1-5(2,3)4/h2*1-7H,14-15H2;(H2,1,2,3,4)

HIDE SMILES / InChI

Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C13H11N3
Molecular Weight 209.2465
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/uk/proflavine-cream-0-1-leaflet.html | https://www.ncbi.nlm.nih.gov/pubmed/22594981 | https://clinicaltrials.gov/ct2/show/NCT02029937

Proflavine is an acriflavine derivative used as a topical disinfectant agains gram-positive bacteria. Proflavine is toxic and carcinogenic in mammals and so it is used only as a surface disinfectant or for treating superficial wounds. Proflavine acts by interchelating DNA (intercalation), thereby disrupting DNA synthesis and leading to high levels of mutation in the copied DNA strands. This prevents bacterial reproduction. Proflavine was investigated for photodynamic theraphy of herpes but was discontinued due to several presentations of post-treatment Bowen's disease and higher lesion recrudescence periods. Proflavine is also investigated as a topical contrast agent for imaging and diagnosis of esophageal, oral, colon, cervical, uterine cancer and polyps.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL3140325
Target ID: CHEMBL2311222
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
PROFLAVINE CREAM 0.1%

Approved Use

For treatment of infected wounds and for skin disinfection
Primary
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Magnetic field effect corroborated with docking study to explore photoinduced electron transfer in drug-protein interaction.
2010-12-30
Synthesis, characterization and cytotoxicity studies of palladium(II)-proflavine complexes.
2010-11
Interaction of bioactive coomassie brilliant blue g with protein: insights from spectroscopic methods.
2010-08-26
Change of the binding mode of the DNA/proflavine system induced by ethanol.
2010-07-01
A fiber-optic fluorescence microscope using a consumer-grade digital camera for in vivo cellular imaging.
2010-06-23
The nature of the force-induced conformation transition of dsDNA studied by using single molecule force spectroscopy.
2010-06-15
"Weighing" photon energies with mass spectrometry: effects of water on ion fluorescence.
2010-05-26
Toxicology and drug delivery by cucurbit[n]uril type molecular containers.
2010-05-06
Design and evaluation of an ultra-slim objective for in-vivo deep optical biopsy.
2010-03-01
[Experimental study of proflavine acetate phototransformation processes].
2010-01-06
Triple dye plus rubbing alcohol versus triple dye alone for umbilical cord care.
2010-01
[Features of binding of proflavine to DNA at different DNA-ligand concentration ratios].
2009-11-10
Equine rhinitis A virus and its low pH empty particle: clues towards an aphthovirus entry mechanism?
2009-10
[Catalytical properties of the liver monoamine oxidases of the commander squid Berryteuthis magister from various habitation zones].
2009-09-22
Stacking interactions and DNA intercalation.
2009-08-13
Abstracts of the 2008 ISSOL Meeting. August 24-29, 2008. Florence, Italy.
2009-08
1H and 13C NMR signal assignments of some new N,N'-diacyl proflavine derivatives.
2009-08
Isothermal microcalorimetry to investigate non specific interactions in biophysical chemistry.
2009-07-28
Precambrian lunar volcanic protolife.
2009-06-11
Photo-inducible cytotoxic and clastogenic activities of 3,6-di-substituted acridines obtained by acylation of proflavine.
2009-06
Complexation of biologically active aromatic compounds with DNA in the presence of theophylline.
2009-05
Solution structure and thermodynamics of 2',5' RNA intercalation.
2009-04-29
Interaction of small molecules with double-stranded RNA: spectroscopic, viscometric, and calorimetric study of hoechst and proflavine binding to PolyCG structures.
2009-04
Fluorophore labeling to monitor tRNA dynamics.
2009
Skipjack tuna (Katsuwonus pelamis) liver monoamine oxidase: substrate-inhibitor analysis.
2008-10-16
Pyrrolo-C as a molecular probe for monitoring conformations of the tRNA 3' end.
2008-10
Electroanalytical study of proflavine intercalation in 5-methyl or inosine-containing amplicons.
2008-10
QacR-cation recognition is mediated by a redundancy of residues capable of charge neutralization.
2008-08-05
Conformational dynamics at the active site of alpha-chymotrypsin and enzymatic activity.
2008-08-05
Colicin E3 cleavage of 16S rRNA impairs decoding and accelerates tRNA translocation on Escherichia coli ribosomes.
2008-07
Role of the third strand in the binding of proflavine and pt-proflavine to poly(rA).2poly(rU): a thermodynamic and kinetic study.
2008-06-12
Self-structure induction in single stranded poly(A) by small molecules: Studies on DNA intercalators, partial intercalators and groove binding molecules.
2008-06-01
Complexation and fluorescence of tricyclic basic dyes encapsulated in cucurbiturils.
2008-04-04
Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas.
2008-04-01
Label free electrochemical DNA hybridization discrimination effects at the binary and ternary mixed monolayers of single stranded DNA/diluent/s in presence of cationic intercalators.
2008-03-14
Over-expression of genes coding for proline oxidase, riboflavin kinase, cytochrome c oxidase and an MFS transporter induced by acriflavin in Trichophyton rubrum.
2008-03
Spectroscopic studies on ligand-enzyme interactions: complexation of alpha-chymotrypsin with 4',6-diamidino-2-phenylindole (DAPI).
2008-02-14
A randomised controlled trial of a double layer of Allevyn compared to Jellonet and proflavin as a tie-over dressing for small skin grafts.
2008
DNA binding by a new metallointercalator that contains a proflavine group bearing a hanging chelating unit.
2008
[Comparative toxicity of photosensitizers in varying destruction].
2007-12-07
Protonation linked equilibria and apparent affinity constants: the thermodynamic profile of the alpha-chymotrypsin-proflavin interaction.
2007-12
Catalytic properties of monoamine oxidase from mink (Mustela vison) liver.
2007-10-16
Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay.
2007-10-16
Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening.
2007-10-15
Characterization of the multidrug efflux regulator AcrR from Escherichia coli.
2007-09-14
Fluorescent labeling of tRNAs for dynamics experiments.
2007-09
On the origin of the decrease in stability of the DNA hairpin d(GCGAAGC) on complexation with aromatic drugs.
2007-08
A rare cause of breast mass that mimics carcinoma: Foreign body reaction to amorphous surgical material.
2007
Progressing single biomolecule force spectroscopy measurements for the screening of DNA binding agents.
2005-10
Amino acridines action on Friend's retrovirus in relation to their molecular ionization.
1989
Patents

Sample Use Guides

Proflavine cream 0.1% is indicated for topical use, to be applied to the affected part 2 - 3 times daily.
Route of Administration: Topical
The minimal inhibition concentration (MIC) of proflavine with respect to various E.coli strains was determined by the twofold dilution method with LB agar containing the proflavine. Bacterial growth was recorded after 18 to 24 h of incubation at 37°C. Proflavine was effective in supressing bacterial growth at 6.5-12.5 ug/mL.
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:34:43 GMT 2025
Edited
by admin
on Mon Mar 31 17:34:43 GMT 2025
Record UNII
27V8M747VB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PROFLAVINE HEMISULFATE
VANDF   WHO-DD  
Common Name English
PROFLAVINE HEMISULFATE [VANDF]
Preferred Name English
NSC-689004
Code English
ACRIDINE, 3,6-DIAMINO-, SULFATE (2:1)
Systematic Name English
NSC-759900
Code English
PROFLAVINE HEMISULPHATE
Common Name English
Proflavine hemisulfate [WHO-DD]
Common Name English
ACRIDINE, 3,6-DIAMINO-, SULPHATE (2:1)
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C28394
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
Code System Code Type Description
NSC
689004
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
DAILYMED
27V8M747VB
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
CAS
1811-28-5
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
FDA UNII
27V8M747VB
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
NCI_THESAURUS
C84109
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
PUBCHEM
9849425
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
DRUG BANK
DBSALT001573
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
RXCUI
8724
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY RxNorm
EPA CompTox
DTXSID4043777
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
NSC
759900
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
SMS_ID
100000085103
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
EVMPD
SUB04058MIG
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
ECHA (EC/EINECS)
217-320-3
Created by admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY